Knowledge Hub

Rapid Growth Of Biological Drugs Market - Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Press Release   •   Jun 05, 2017 06:05 EDT

About Biological Drugs Market

Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Biological drugs include therapeutic proteins, monoclonal antibody (mAb) and vaccines. The biological drugs market is growing due to the increasing prevalence of chronic diseases and the demand for biological drugs is growing due to the increase in the global geriatric population. Moreover, various government associations are also supporting in growth of biological drugs market. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.

On the other hand, high cost of biologic drugs and patent expiry of blockbuster drugs impede the growth of the biological drugs market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the biological drugs market.

Get Sample Copy of this report @

The report provides in-depth analysis and estimation of the biological drugs market from 2014 to 2020, considering 2013 as the base year for calculation. Additionally, data pertaining to current market dynamics including market drivers, restraints, trends and recent developments has been provided in the biological drugs market report. The global biological drugs market is categorized based on therapeutic protein, monoclonal antibody (mAb), vaccine and geography. The therapeutic protein segmentation is further sub-segmented into Enbrel, Lantus, Neulasta, Avonex, NovoLog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, and Eylea. The mAb segment comprises Humira, Remicade, Rituxan, Avastin, Herceptin and Lucentis. The vaccine segment is further sub-segmented into Prevnar 13, Gardasil, Fluzone, Varivax and Cervarix.

View Report @

Under geographic analysis, the report identifies and analyses the biological drugs market size and provides forecasts for the markets in North America, Europe, Asia and Rest of the World (RoW). Major players operating in the biological drugs market are Pfizer Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, GlaxoSmithKline plc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen Inc., Baxter International Inc. and Biogen Idec. These key market players have been profiled based on attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Table of Contents

Chapter 1 Preface

1.1 Report Description

1.2 Research methodology

1.2.1 Sources Secondary Research Primary Research Assumptions

Chapter 2 Executive Summary

Chapter 3 Global Biological Drugs Market – Industry Analysis

3.1 Introduction

3.2 Market Drivers

3.2.1 Increasing prevalence of chronic diseases enhance the market growth

3.2.2 Globally geriatric population increases the demand of biological drugs

3.2.3 Various government associations are promoting usage of biological drugs

3.3 Market Opportunities

3.3.1 Advancement in biomedical science promises to boost the development of new biological products

3.4 Restraints

3.4.1 High cost of biological drugs impedes market growth

3.4.2 Patent expiration of various blockbuster biological drugs

3.4.3 Risk of adverse effects associated with biological injectable medicines

Chapter 4 Market Trends

4.1.1 Increasing use of anti-Vascular Endothelial Growth Factor (VEGF) therapy is gaining popularity in biopharmaceutical industry

4.1.2 Genetically Modified Organisms (GMOs) are gaining importance in biological drugs market

Chapter 5 Porter’s Five Forces Analysis

5.1.1 Bargaining power of suppliers

5.1.2 Bargaining power of buyers

5.1.3 Threat of new entrants

5.1.4 Threat of substitutes

5.1.5 Degree of competition

Chapter 6 Global Market Size and Forecast

Chapter 7 Segment Analysis, by Therapeutic Protein

7.1 Enbrel

7.2 Lantus

7.3 Neulasta

7.4 Avonex

7.5 NovoLog

7.6 Rebif

7.7 Humalog

7.8 Aranesp

7.9 Epogen

7.10 Levemir

7.11 Victoza

7.12 Betaseron

7.13 Neupogen

7.14 Eylea

Chapter 8 Segment Analysis, by mAb

8.1 Humira

8.2 Remicade

8.3 Rituxan

8.4 Avastin

8.5 Herceptin

8.6 Lucentis is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.